Nomura Holdings Inc. Buys 7,684 Shares of Bruker Co. (NASDAQ:BRKR)

Nomura Holdings Inc. grew its stake in Bruker Co. (NASDAQ:BRKR - Free Report) by 109.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,684 shares of the medical research company's stock after acquiring an additional 7,684 shares during the quarter. Nomura Holdings Inc.'s holdings in Bruker were worth $861,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Quadrant Capital Group LLC increased its stake in shares of Bruker by 18.2% in the 4th quarter. Quadrant Capital Group LLC now owns 1,273 shares of the medical research company's stock valued at $75,000 after acquiring an additional 196 shares during the last quarter. Insigneo Advisory Services LLC increased its stake in shares of Bruker by 4.7% in the 4th quarter. Insigneo Advisory Services LLC now owns 4,880 shares of the medical research company's stock valued at $286,000 after acquiring an additional 218 shares during the last quarter. Arizona State Retirement System increased its stake in shares of Bruker by 0.7% in the 4th quarter. Arizona State Retirement System now owns 30,725 shares of the medical research company's stock valued at $1,801,000 after acquiring an additional 222 shares during the last quarter. CIBC Asset Management Inc increased its stake in shares of Bruker by 5.6% in the 4th quarter. CIBC Asset Management Inc now owns 4,233 shares of the medical research company's stock valued at $248,000 after acquiring an additional 223 shares during the last quarter. Finally, UMB Bank n.a. increased its stake in shares of Bruker by 37.5% in the 4th quarter. UMB Bank n.a. now owns 909 shares of the medical research company's stock valued at $53,000 after acquiring an additional 248 shares during the last quarter. 79.52% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Guggenheim reiterated a "buy" rating on shares of Bruker in a research report on Monday, February 24th. Stifel Nicolaus decreased their price objective on Bruker from $57.00 to $48.00 and set a "hold" rating for the company in a research report on Thursday, May 8th. Citigroup decreased their price objective on Bruker from $75.00 to $50.00 and set a "buy" rating for the company in a research report on Monday, April 7th. UBS Group decreased their price objective on Bruker from $57.00 to $45.00 and set a "neutral" rating for the company in a research report on Thursday, May 8th. Finally, Wells Fargo & Company decreased their price objective on Bruker from $75.00 to $60.00 and set an "overweight" rating for the company in a research report on Thursday, April 17th. Six analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $60.10.

Bruker Trading Up 0.7%

NASDAQ:BRKR opened at $37.80 on Tuesday. Bruker Co. has a twelve month low of $34.10 and a twelve month high of $78.94. The company has a quick ratio of 0.77, a current ratio of 1.60 and a debt-to-equity ratio of 1.15. The business has a 50 day moving average price of $40.19 and a two-hundred day moving average price of $50.26. The company has a market cap of $5.73 billion, a P/E ratio of 49.74, a price-to-earnings-growth ratio of 2.16 and a beta of 1.23.

Bruker (NASDAQ:BRKR - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The medical research company reported $0.47 earnings per share for the quarter, topping analysts' consensus estimates of $0.46 by $0.01. Bruker had a return on equity of 21.01% and a net margin of 3.36%. The firm had revenue of $801.40 million during the quarter, compared to the consensus estimate of $763.83 million. During the same quarter in the prior year, the firm posted $0.53 EPS. The business's revenue was up 11.0% on a year-over-year basis. As a group, analysts expect that Bruker Co. will post 2.69 EPS for the current fiscal year.

Bruker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 27th. Stockholders of record on Monday, June 16th will be issued a $0.05 dividend. This represents a $0.20 annualized dividend and a dividend yield of 0.53%. The ex-dividend date is Monday, June 16th. Bruker's payout ratio is presently 38.46%.

Bruker Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Co. (NASDAQ:BRKR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.